Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Annual Report
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Fees
Hotel
Venue
Helpful info
Eco-friendly info
Programme
Abstracts
Postgraduate Teaching
Nurse Programme
Hands-on
Information for Presenters
In-person Networking
myUEG Community Area
Learn from Leaders
Mentoring
The UEG Night
Let's Meet
Industry Programme
Industry Exhibition
Industry Symposia
Acknowledgements
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass on Chronic Pancreatitis
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Research
To landing page
Support
Horizon Europe Support
Research Prize
Research Fellowship
Research Webinars
Advocacy
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
Guideline development framework
Get Funding
Get Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Digestive Health Month
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Application Support
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Gerassimos J. Mantzaris
THE NATURAL HISTORY OF COVID-19 IN VACCINATED INFLAMMATORY BOWEL DISEASE PATIENTS
TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE
SIMPLIFIED RULES TO IDENTIFY BIO-NAÏVE PATIENTS WITH CROHN'S DISEASE WITH HIGHER LIKELIHOOD OF CLINICAL REMISSION WHEN INITIATING VEDOLIZUMAB VERSUS ANTI-TNF THERAPIES: ANALYSIS OF EVOLVE STUDY DATA
SIMPLIFIED RULES TO IDENTIFY BIO-NAÏVE PATIENTS WITH CROHN’S DISEASE WITH HIGHER LIKELIHOOD OF CLINICAL REMISSION WHEN INITIATING VEDOLIZUMAB VERSUS ANTI-TNF THERAPIES: ANALYSIS OF EVOLVE STUDY DATA
Gerassimos J. Mantzaris
et al.
Joint manifestations and their effect on treatment options
Gerassimos J. Mantzaris
AN ELUSIVE MANIFESTATION OF COVID-19: DYSPHAGIA DUE TO ESOPHAGO-GASTRIC JUNCTION DISORDERS
Gerassimos J. Mantzaris
et al.
LEADING FACTORS OF LIVER INJURY AMONG HOSPITALIZED PATIENTS WITH COVID-19: EXPERIENCE FROM A COVID-19 REFERRAL HOSPITAL
Gerassimos J. Mantzaris
et al.
EFFECTS OF COVID-19 ON EMPLOYMENT IN IBD PATIENTS
Gerassimos J. Mantzaris
et al.
MENTAL HEALTH, WORK PRESENTEEISM AND EXERCISE IN IBD PATIENTS
Gerassimos J. Mantzaris
et al.
European Crohn’s and Colitis Organisation Topical Review on Environmental Factors in IBD
Gerassimos J. Mantzaris
et al.
THE INFLAMMATORY BOWEL DISEASE – DISK TOOL FOR ASSESSING DISABILITY IN INFLAMMATORY BOWEL DISEASE PATIENTS: VALIDATION OF THE GREEK VERSION
Gerassimos J. Mantzaris
et al.
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
Gerassimos J. Mantzaris
et al.
TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE
Gerassimos J. Mantzaris
et al.
THE NATURAL HISTORY OF COVID-19 IN VACCINATED INFLAMMATORY BOWEL DISEASE PATIENTS
Gerassimos J. Mantzaris
et al.
THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB
Gerassimos J. Mantzaris
et al.
THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD
Gerassimos J. Mantzaris
et al.
HEAVY PSEUDOPOLYP BURDEN IN INFLAMMATORY BOWEL DISEASE PREDICTS MORE SEVERE DISEASE: A MULTICENTRE COHORT STUDY
Gerassimos J. Mantzaris
et al.
COMPROMISED PERFORMANCE OF LUGOL CHROMOENDOSCOPY AND ASSOCIATED ENDOSCOPIC PATTERNS IN PATIENTS WITH ADVANCED ACHALASIA
Gerassimos J. Mantzaris
et al.
Item 1 - 18 / 18
1
Chat with us
, powered by
LiveChat